Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Cited In for PubMed (Select 17660266)

1.

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

de Ferranti SD, de Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ, Zinman B, Eckel RH.

Diabetes Care. 2014 Oct;37(10):2843-63. doi: 10.2337/dc14-1720. Epub 2014 Aug 11. Review. No abstract available.

PMID:
25114297
2.

Early diabetic nephropathy in type 1 diabetes: new insights.

Bjornstad P, Cherney D, Maahs DM.

Curr Opin Endocrinol Diabetes Obes. 2014 Aug;21(4):279-86. doi: 10.1097/MED.0000000000000074. Review.

3.

Fasting blood glucose--a missing variable for GFR-estimation in type 1 diabetes?

Bjornstad P, McQueen RB, Snell-Bergeon JK, Cherney D, Pyle L, Perkins B, Rewers M, Maahs DM.

PLoS One. 2014 Apr 29;9(4):e96264. doi: 10.1371/journal.pone.0096264. eCollection 2014.

4.

The association between renal function biomarkers and subclinical cardiovascular measures in African Caribbean families.

Li H, Kuipers A, Kammerer CM, Bunker CH, Kuller LH, Miljkovic I, Patrick AL, Wheeler VW, Zmuda JM.

Ethn Dis. 2013 Autumn;23(4):492-8.

5.

Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study.

Maahs DM, Jalal D, Chonchol M, Johnson RJ, Rewers M, Snell-Bergeon JK.

Diabetes Care. 2013 Sep;36(9):2607-14. doi: 10.2337/dc12-2538. Epub 2013 Jul 8.

6.

Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study).

He J, Reilly M, Yang W, Chen J, Go AS, Lash JP, Rahman M, DeFilippi C, Gadegbeku C, Kanthety R, Tao K, Hamm LL, Ojo A, Townsend R, Budoff M; CRIC Investigators.

Am J Cardiol. 2012 Dec 15;110(12):1735-41. doi: 10.1016/j.amjcard.2012.07.044. Epub 2012 Sep 14.

7.

Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.

Dupont M, Wu Y, Hazen SL, Tang WH.

Circ Heart Fail. 2012 Sep 1;5(5):602-9. Epub 2012 Aug 16.

8.

Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.

Lertnawapan R, Bian A, Rho YH, Raggi P, Oeser A, Solus JF, Gebretsadik T, Shintani A, Stein CM.

Lupus. 2012 Mar;21(3):279-87. doi: 10.1177/0961203311425527. Epub 2011 Nov 9.

9.

Age and sex influence cystatin C in adolescents with and without type 1 diabetes.

Maahs DM, Prentice N, McFann K, Snell-Bergeon JK, Jalal D, Bishop FK, Aragon B, Wadwa RP.

Diabetes Care. 2011 Nov;34(11):2360-2. doi: 10.2337/dc11-0829. Epub 2011 Sep 16.

10.

Systematic shifts in cystatin C between 2006 and 2010.

Maahs DM, Jalal D, McFann K, Rewers M, Snell-Bergeon JK.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1952-5. doi: 10.2215/CJN.11271210. Epub 2011 Jul 22.

11.

Reduced heart rate variability predicts progression of coronary artery calcification in adults with type 1 diabetes and controls without diabetes.

Rodrigues TC, Ehrlich J, Hunter CM, Kinney GL, Rewers M, Snell-Bergeon JK.

Diabetes Technol Ther. 2010 Dec;12(12):963-9. doi: 10.1089/dia.2010.0070.

12.

Is cystatin C an important prognostic marker independent of renal function?

Chen HH.

J Am Coll Cardiol. 2010 Nov 30;56(23):1937-8. doi: 10.1016/j.jacc.2010.06.049. No abstract available.

13.

Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.

Satoh-Asahara N, Suganami T, Majima T, Kotani K, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Himeno A, Kono S, Sugawara A, Hattori M, Ogawa Y, Shimatsu A; Japan Obesity and Metabolic Syndrome Study (JOMS) Group.

Clin J Am Soc Nephrol. 2011 Feb;6(2):265-73. doi: 10.2215/CJN.04830610. Epub 2010 Nov 4.

14.

Response: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100).

Kim EH, Lee KU.

Korean Diabetes J. 2010 Jun;34(3):209-10. doi: 10.4093/kdj.2010.34.3.209. Epub 2010 Jun 30. No abstract available.

15.

Letter: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100).

Won KC.

Korean Diabetes J. 2010 Jun;34(3):207-8. doi: 10.4093/kdj.2010.34.3.207. Epub 2010 Jun 30. No abstract available.

16.

Augmentation pressure and subendocardial viability ratio are associated with microalbuminuria and with poor renal function in type 1 diabetes.

Prince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA, Orchard TJ.

Diab Vasc Dis Res. 2010 Jul;7(3):216-24. doi: 10.1177/1479164110375297. Epub 2010 Jul 6.

17.

Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients.

Kim EH, Yu JH, Lee SA, Kim EY, Kim WG, Lee SH, Cho EH, Koh EH, Lee WJ, Kim MS, Park JY, Lee KU.

Korean Diabetes J. 2010 Apr;34(2):95-100. doi: 10.4093/kdj.2010.34.2.95. Epub 2010 Apr 30.

18.

Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes.

Maahs DM, Snell-Bergeon JK, Hokanson JE, Kinney GL, Berl T, Rewers M, Ogden LG.

Diabetes Technol Ther. 2010 Jan;12(1):25-33. doi: 10.1089/dia.2009.0086.

19.

Higher fibrinogen levels predict progression of coronary artery calcification in adults with type 1 diabetes.

Rodrigues TC, Snell-Bergeon JK, Maahs DM, Kinney GL, Rewers M.

Atherosclerosis. 2010 Jun;210(2):671-3. doi: 10.1016/j.atherosclerosis.2009.12.034. Epub 2010 Jan 4.

20.

Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study.

Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, Snell-Bergeon JK.

Nephrol Dial Transplant. 2010 Jun;25(6):1865-9. doi: 10.1093/ndt/gfp740. Epub 2010 Jan 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk